GIS:FRA
गिलियड साइन्सेस
€ १५३.२०
arrow_upward
+०.२२%(+०.३४) 1D
नोभेम्बर १२, २२:००:०० GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
€ १५३.५६
High
€ १५३.५८
Low
€ १५३.२०
Mkt. cap
२.०८ खरब
Avg. vol.
१९८.००
Volume
१२०.००
52-wk high
€ १५७.१४
52-wk low
€ १००.४२
No. of employees
१७ हजार
Open
€ १५३.५६
High
€ १५३.५८
Low
€ १५३.२०
Mkt. cap
२.०८ खरब
Avg. vol.
१९८.००
Volume
१२०.००
52-wk high
€ १५७.१४
52-wk low
€ १००.४२
No. of employees
१७ हजार
News stories
From web sources and news partners
Yahoo! Finance Canada
·
३ घण्टा पहिले
Compugen Ltd (CGEN) Q3 2026 Earnings Call Highlights: Revenue Doubles as Gilead and AstraZeneca ...
MarketWatch
·
५ घण्टा पहिले
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors
Yahoo Finance
·
६ घण्टा पहिले
Top Research Reports for Home Depot, Gilead & TotalEnergies
Zacks Investment Research
·
८ घण्टा पहिले
Can Gilead Sciences' HIV Business Fuel Sustainable Long-Term Growth?
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About गिलियड साइन्सेस
CEODaniel O'Day
Employees१७ हजार
Founded१९८७ जुन २२
HeadquartersFoster City, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitegilead.com